» Articles » PMID: 20684592

Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D

Abstract

The synthesis and biological evaluation of potent and selective PKD inhibitors are described herein. The compounds described in the present study selectively inhibit PKD among other putative HDAC kinases. The PKD inhibitors of the present study blunt phosphorylation and subsequent nuclear export of HDAC4/5 in response to diverse agonists. These compounds further establish the central role of PKD as an HDAC4/5 kinase and enhance the current understanding of cardiac myocyte signal transduction. The in vivo efficacy of a representative example compound on heart morphology is reported herein.

Citing Articles

Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions.

Wang Q, Wipf P J Med Chem. 2022; 66(1):122-139.

PMID: 36538005 PMC: 10228507. DOI: 10.1021/acs.jmedchem.2c01599.


Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure.

Bossuyt J, Borst J, Verberckmoes M, Bailey L, Bers D, Hegyi B J Am Heart Assoc. 2022; 11(19):e027573.

PMID: 36172952 PMC: 9673734. DOI: 10.1161/JAHA.122.027573.


Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy.

Lv D, Chen H, Feng Y, Cui B, Kang Y, Zhang P Front Oncol. 2021; 11:680221.

PMID: 34249722 PMC: 8263921. DOI: 10.3389/fonc.2021.680221.


Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.

Zhang X, Connelly J, Chao Y, Wang Q Biomolecules. 2021; 11(3).

PMID: 33807058 PMC: 8005150. DOI: 10.3390/biom11030483.


The oncogenic role of protein kinase D3 in cancer.

Liu Y, Song H, Zhou Y, Ma X, Xu J, Yu Z J Cancer. 2021; 12(3):735-739.

PMID: 33403031 PMC: 7778554. DOI: 10.7150/jca.50899.